Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. AAPL
2. BRZE
3. TTAN
4. CHYM
5. USO
6. COO
7. QCOM
8. IRT
9. AEO
10. LEU

Go back to Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma
REPROS THERAPEUTICS (NASDAQ: RPRX) Delayed: 60.59 --0 (-0%)
Previous Close $60.59    52 Week High $3.48 
Open $60.60    52 Week Low $0.80 
Day High $60.80    P/E N/A 
Day Low $59.31    EPS $-1.54 
Volume 4,344,502       

(NASDAQ: ZYME) Delayed: 27.15 -0.96 (3.42%)
Previous Close $28.11    52 Week High $ 
Open $27.81    52 Week Low $ 
Day High $28.09    P/E N/A 
Day Low $27.08    EPS $ 
Volume 396,032